Nanometric biocompatible Metal-Organic Frameworks (nanoMOFs) are promising candidates for drug delivery. Up to now, most studies have targeted the intravenous route, related to pain and severe complications; whereas nanoMOFs for oral administration, a commonly used non-invasive and simpler route, remains however unexplored. We propose here the biofriendly preparation of a suitable oral nanocarrier based on the benchmarked biocompatible mesoporous iron(III) trimesate nanoparticles coated with the bioadhesive polysaccharide chitosan (CS). This method does not hamper the textural/structural properties and the sorption/release abilities of the nanoMOFs upon surface engineering. The interaction between the CS and the nanoparticles has been characterized through a combination of high resolution soft X-ray absorption and computing simulation, while the positive impact of the coating on the colloidal and chemical stability under oral simulated conditions is here demonstrated. Finally, the intestinal barrier bypass capability and biocompatibility of CS-coated nanoMOF have been assessed in vitro, leading to an increased intestinal permeability with respect to the non-coated material, maintaining an optimal biocompatibility. In conclusion, the preservation of the interesting physicochemical features of the CS-coated nanoMOF and their adapted colloidal stability and progressive biodegradation, together with their improved intestinal barrier bypass, make these nanoparticles a promising oral nanocarrier.
Halide perovskites have emerged at the forefront of semiconductor materials for photovoltaic and light‐emitting devices. However, long‐term stability and toxicity are the major barriers to their commercialization. In particular, the toxicity of lead (Pb) and its environmental impact have prompted the exploration of lead‐free alternatives like tin (Sn) and bismuth (Bi). Herein, a cytotoxicity study of Pb‐based perovskite (CsPbBr3 and CsPbI3) and a lead‐free Cs2AgBiBr6 nanocrystals in lung and liver cell lines and in blood cells are reported, revealing that both Pb and Bi exhibit mitogenic effects and oxidative stress in liver cells, cytotoxicity in pulmonary cells and a dose‐dependent hemolytic effect, raising concerns about their potential pulmonary‐hepato‐hemotoxicity. The zebrafish embryo tests reveal SnBr2 displays a notably safer environmental impact profile at elevated concentrations, while Pb and Bi exhibit dose‐dependent toxicity. This study provides compelling evidence that Sn compounds demonstrate a safer toxicity profile in both human cells and aquatic organisms under the studied conditions, supporting their potential as a more environmentally friendly alternative. In contrast, Bi compounds exhibit a toxicity profile similar to Pb perovskites, warranting caution in its use as a substitute. These findings guide future research and regulatory efforts in the safety and sustainability of perovskite nanocrystals.
1 January 2014 in Colloids and Surfaces B: Biointerfaces